CSBR · Champions Oncology Inc
United States · RS rating 34 · As of 2026-11-03
| Price | 4.83 USD |
|---|---|
| 1-day change | +0.4% |
| RS rating (overall / 1M / 3M / 12M) | 34 / 49 / 48 / 31 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 16 / 9 / 5 |
| Industry group (rank) | Medical-Research Eqp/Svc (46) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +10.1% |
| Distance from 52-week high | +38.1% |
| Market cap (USD) | $83.9M |